Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current research.

Publication date: Jul 03, 2025

Psychological stress plays a critical role in the onset of depression by activating neuroimmune and endocrine responses, leading to dysregulation of the hypothalamic-pituitary-adrenal axis and increased inflammation. This imbalance impacts key brain regions involved in mood regulation, such as the prefrontal cortex, hippocampus, and amygdala, contributing to the development of depressive symptoms. Moreover, stress induces immune dysregulation and inflammation in peripheral organs, including the gut, spleen, liver, lungs, and heart, which can result in metabolic disorders, cardiovascular disease, and immune dysfunction. Chronic stress also disrupts gut microbiota and alters the gut-brain axis via the vagus nerve, further exacerbating stress-related mental health issues. The cumulative effect of stress on peripheral organs significantly impacts both physical and mental health, linking systemic dysfunction to depression. This comprehensive review delves into the intricate mechanisms by which the immune system regulates mood and explores the etiological factors underlying dysregulated inflammatory responses in depression. We also summarize the connections between the brain and peripheral organs-bone marrow, spleen, gut, adipose tissue, heart, liver, lungs, and muscles-highlighting their coordinated regulation of immune function in response to psychological stress. Additionally, we investigate specific brain regions and neuronal populations that respond to stress stimuli, transmitting signals through autonomic and neuroendocrine pathways to modulate immune function. Finally, we discuss emerging therapeutic strategies that leverage the interaction between endocrine signaling and inflammatory responses for the effective treatment of depression.

Open Access PDF

Concepts Keywords
Depression Axis
Etiological Brain
Liver Depression
Marrow Dysregulation
Neuroimmune Endocrine
Gut
Immune
Impacts
Inflammation
Neuroimmune
Organs
Peripheral
Psychological
Regions
Stress

Semantics

Type Source Name
disease MESH psychological stress
disease MESH depression
disease MESH inflammation
disease MESH cardiovascular disease
pathway REACTOME Immune System
pathway REACTOME Metabolism
drug DRUGBANK Isoxaflutole
drug DRUGBANK Hydrocortisone
disease MESH glucocorticoid resistance
disease MESH anxiety
drug DRUGBANK Coenzyme M
disease MESH major depressive disorder
disease MESH physical barriers
disease MESH malaria
pathway KEGG Malaria
disease MESH psychiatric disorders
disease MESH bipolar disorder
disease MESH schizophrenia
disease MESH psychosis
disease MESH hepatitis
drug DRUGBANK Trestolone
disease MESH violence
disease MESH physiological stress
pathway REACTOME Digestion
drug DRUGBANK Corticorelin
drug DRUGBANK Corticotropin
drug DRUGBANK Corticosterone
disease MESH atrophy
pathway REACTOME Methylation
disease MESH early life stress
pathway REACTOME Innate Immune System
disease MESH infections
pathway REACTOME Adaptive Immune System
disease MESH mood disorders
disease MESH low socioeconomic status
disease MESH pathogenesis
disease MESH neuroinflammation
disease MESH autoimmune diseases
disease MESH immune tolerance
disease MESH CNS infections
pathway KEGG Thermogenesis
drug DRUGBANK Acetylcysteine
disease MESH lymphocytopenia
drug DRUGBANK Norepinephrine
disease MESH viral infections
disease MESH splenomegaly
pathway REACTOME Heme biosynthesis
pathway KEGG Oxidative phosphorylation
disease MESH abnormalities
drug DRUGBANK Diminazene
drug DRUGBANK Serotonin
disease MESH Dysbiosis
disease MESH brain inflammation
pathway KEGG Metabolic pathways
drug DRUGBANK gamma-Aminobutyric acid
pathway REACTOME Fatty acids
disease MESH tryptophan
drug DRUGBANK L-Tryptophan
disease MESH colitis
drug DRUGBANK Water
drug DRUGBANK Ethanol
drug DRUGBANK Dextran
drug DRUGBANK Sodium sulfate
drug DRUGBANK Leptin
disease MESH insulin sensitivity
drug DRUGBANK Dopamine
disease MESH hyperglycemia
pathway REACTOME Gluconeogenesis
drug DRUGBANK Angiotensin II
drug DRUGBANK Aldosterone
drug DRUGBANK Acetylcholine
disease MESH infarction
disease MESH myocardial infarction
drug DRUGBANK Sotagliflozin
drug DRUGBANK Dextrose unspecified form
disease MESH non alcoholic fatty liver disease
pathway KEGG Insulin resistance
disease MESH obesity
disease MESH liver diseases
disease MESH cognitive impairments
drug DRUGBANK Ammonia
disease MESH acute liver failure
disease MESH ischemia
drug DRUGBANK Sulforaphane
drug DRUGBANK Arachidonic Acid
disease MESH neurological disorders
disease MESH lung injury
disease MESH demyelination
disease MESH endotoxemia
disease MESH respiratory failure
disease MESH asthma
pathway KEGG Asthma
drug DRUGBANK Neomycin
disease MESH rhinosinusitis
disease MESH bacterial pneumonia
drug DRUGBANK Maltose
drug DRUGBANK Kynurenic Acid
disease MESH aids
pathway REACTOME Muscle contraction
drug DRUGBANK Celecoxib
drug DRUGBANK Bupropion
drug DRUGBANK Cannabidiol
disease MESH treatment resistant depression
drug DRUGBANK Ibuprofen
drug DRUGBANK Escitalopram
drug DRUGBANK Citalopram
drug DRUGBANK Fluoxetine
drug DRUGBANK Imipramine
drug DRUGBANK Acetylsalicylic acid
drug DRUGBANK Ketamine
drug DRUGBANK Esketamine
drug DRUGBANK Spinosad
disease MESH chronic renal failure
disease MESH lipid metabolism disorders
drug DRUGBANK Liothyronine
drug DRUGBANK Oxytocin
disease MESH syndrome
drug DRUGBANK Tretamine
disease MESH necrosis
drug DRUGBANK Natural alpha interferon
drug DRUGBANK Ribavirin
disease MESH depressive disorders
disease MESH Arthritis
disease MESH autoimmunity
drug DRUGBANK Dexamethasone
drug DRUGBANK Diazepam
drug DRUGBANK Nandrolone phenpropionate
drug DRUGBANK Carboxyamidotriazole
disease MESH delirium
drug DRUGBANK Lisuride
disease MESH COVID 19
disease MESH long COVID
drug DRUGBANK Vorinostat
drug DRUGBANK (S)-Des-Me-Ampa
pathway KEGG Tryptophan metabolism
drug DRUGBANK Lanicemine
drug DRUGBANK Lactobacillus reuteri
disease MESH anhedonia
drug DRUGBANK Diflunisal
drug DRUGBANK Ferrous sulfate anhydrous
drug DRUGBANK Guanosine
disease MESH pancreatic diseases
disease MESH hepatic encephalopathy
disease MESH encephalopathy
disease MESH Shock
disease MESH neurodevelopmental disorders
drug DRUGBANK Glyphosate
disease MESH autism
disease MESH carcinogenesis
disease MESH lung inflammation
disease MESH Alzheimer’s disease
pathway KEGG Proteasome
drug DRUGBANK Gold
drug DRUGBANK Nonoxynol-9
drug DRUGBANK O1-Methyl-Glucose
disease MESH bone diseases
pathway REACTOME Reproduction

Original Article

(Visited 7 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *